Pabau Engage inbox

Pabau Engage is here: every patient conversation in one inbox.

Learn more
CPT Code

CPT code 21030 – Benign tumor excision of maxilla or zygoma


Code Definition

21030 is the CPT code for excision of a benign tumor or cyst of the maxilla or zygoma by enucleation and curettage. It covers bony lesions of the upper jaw and cheekbone that pathology confirms as benign.

The AMA places 21030 in the Head subsection (21010-21499) of the Musculoskeletal System section. A malignant tumor at the same site bills under CPT 21034, and a benign mandibular lesion under 21040.

Section
10004-69990 Surgery
Subsection
20100-29999 Musculoskeletal system
Code range
21010-21499 Head
Billable
No
Code also known as
maxillary cyst excision, zygomatic lesion removal, jaw tumor removal, odontogenic cyst excision
Save time. Improve accuracy. Get paid faster.
Automate coding with Pabau

Let Pabau's smart automation suggest the right codes, reduce claim denials, and keep your practice compliant—effortlessly.

  • AI-powered code suggestions
  • Real-time compliance checks
  • Faster claims, fewer denials
Why practices choose Pabau
Save hours every week

Automate repetitive tasks and focus on what matters most—your patients.

Improve accuracy

Reduce coding errors and ensure compliance with the latest regulations.

Get paid faster

Clean claims, fewer denials, and faster reimbursements.

Grow with confidence

Powerful insights and reporting to help your practice thrive.

HIPAA compliant SOC 2 certified GDPR-compliant Trusted by 4,000+ clinics worldwide

Key takeaways

Key takeaways

CPT code 21030 covers excision of a benign tumor or cyst of the maxilla or zygoma, never a soft-tissue or mandibular lesion.

Pair it with D16.4 for a benign bone tumor, K09.0 for a developmental odontogenic cyst, or M27.49 for another jaw cyst, as pathology confirms.

Claims are most often denied for missing pathology confirmation, a wrong ICD-10 pairing, or prior authorization that a commercial payer required but nobody obtained.

Medicare’s CY2026 work RVU for 21030 is 4.79, and the national rate is about $338 in a facility and $478 outside one.

Pabau’s practice management software submits 21030 claims through Claim.MD and warns when a required prior authorization code is missing.

CPT code 21030: Official descriptor and clinical scope

CPT code 21030 describes “excision of benign tumor or cyst of maxilla or zygoma by enucleation and curettage.” The code covers surgical removal of bony lesions. The lesion must originate in, or be attached to, the cortical or trabecular bone of the maxilla (upper jaw) or zygoma (cheekbone). It does not apply to lesions arising in the adjacent soft tissue of the dentoalveolar structures.

The two anatomical sites covered are distinct from a billing standpoint. Maxillary lesions are the more common case, typically odontogenic cysts or benign ossifying tumors. A developmental odontogenic cyst takes ICD-10-CM K09.0 rather than a neoplasm code. Zygomatic arch lesions are less frequent and may involve fibrous dysplasia or giant cell tumors. Both sites fall under 21030 as long as the pathology confirms benign status.

“Benign” in this context is a pathology-confirmed designation, not a clinical assumption. The operative note must reference intent to excise a bony lesion, and the pathology report must confirm the absence of malignancy. Without that confirmation, payers may deny the claim as lacking medical necessity documentation.

What CPT 21030 includes and excludes

Understanding where 21030 begins and ends prevents the most common upcoding and downcoding errors in oral and maxillofacial surgery billing.

Included under 21030

  • Enucleation: Complete removal of the lesion from its bony cavity, commonly used for odontogenic cysts
  • Curettage: Scraping of the bony margins to remove residual lining tissue after enucleation
  • Excision of bony outgrowths or ossifying lesions: When the lesion is bony in origin and confirmed benign
  • Lesions on both sides: CMS gives 21030 a bilateral surgery indicator of 1, so Medicare pays 150% for a bilateral procedure. Report it with modifier 50 or with LT and RT, as each payer requires

Excluded from 21030

  • Malignant tumors of the maxilla or zygoma: Use CPT 21034
  • Benign tumor of the mandible: Use CPT 21040 (mandible-specific excision code)
  • Torus mandibularis: Use CPT 21031 (excision of torus mandibularis)
  • Torus palatinus (maxillary torus): Use CPT 21032
  • Soft-tissue lesions of dentoalveolar structures: Use CPT 41825 or similar soft-tissue codes
  • Benign facial-bone tumors removed by contouring (e.g., fibrous dysplasia): Use CPT 21029

How the procedure is performed and documented

Payers reviewing a CPT 21030 claim look for a clear chain from pre-operative imaging through to pathology confirmation. The documentation decides whether the claim holds up.

A maxillary or zygomatic lesion excision typically runs through these steps:

  • Mucosal incision and flap elevation
  • Exposure of the bony lesion
  • Enucleation or block excision of the lesion
  • Curettage of the bony margins
  • Irrigation and primary closure

The operative note does not need a paragraph per step. It must name the site, the approach, and the technique used.

Most commercial and Medicare plans ask for the same documentation on a CPT 21030 claim. An operative note template with required fields for site, approach and technique stops the note from being signed without them.

Pabau form builder showing a template library next to a medical history form preview
Pabau’s digital forms build operative note templates with required fields, so the site and technique are recorded before anyone codes the 21030 claim.
Documentation elementWhat to includeWhy it matters for claims
Operative noteSite (maxilla vs zygoma), approach, technique, lesion sizeEstablishes code selection and rules out adjacent codes
Pathology reportBenign diagnosis with specific histologic typeConfirms benign status required by CPT descriptor
Pre-op imagingCT or panoramic radiograph showing bony lesionSupports medical necessity, and is often required for prior auth
Clinical notesPresenting symptoms, examination findings, prior treatmentSupports medical necessity for payers requiring LCD compliance

ICD-10 codes to pair with CPT 21030

The ICD-10-CM pairing for CPT code 21030 depends on the bony site in the operative note and the histologic type pathology confirms. Using a soft-tissue diagnosis code when the lesion is bony is the most frequent pairing error on these claims.

ICD-10-CM codeDescriptionWhen to use
D16.4Benign neoplasm of bones of skull and faceBenign tumor of the maxilla or zygomatic bone confirmed by pathology, including an odontogenic keratocyst
K09.0Developmental odontogenic cystsDevelopmental odontogenic cyst of the maxilla, such as a dentigerous or lateral periodontal cyst
K09.1Developmental (nonodontogenic) cysts of oral regionNonodontogenic developmental cyst of the maxilla, such as a nasopalatine duct cyst
M27.49Other cysts of jawJaw cyst that is not a neoplasm, such as a solitary (traumatic or hemorrhagic) or aneurysmal bone cyst
M27.1Giant cell granuloma, centralCentral giant cell lesion of the jaw confirmed by pathology as non-malignant
D16.5Benign neoplasm of lower jaw boneNot a 21030 pairing. A mandibular lesion bills under 21040, so D16.5 on a 21030 claim signals a site mismatch

Verify every ICD-10-CM code against the CDC/NCHS ICD-10-CM web tool for the current fiscal year before submission. Codes are updated annually, and a code valid in FY 2025 may carry a different description in FY 2026. A Stafne defect, or latent bone cyst, codes to M27.0, and other oral-region cysts not classified elsewhere fall to K09.8.

CPT 21030 vs adjacent codes: Choosing the right code

The excision codes around 21030 cover a narrow anatomical and clinical range. Code selection turns on three questions: which bone, whether the lesion is benign or malignant, and how it was removed. The mandibular twin, 21040, is the code coders swap with 21030 most often. The guide below walks through the three questions in order.

Decision guide for CPT excision codes
Seven codes split on three facts from the chart, and 21030 needs all three to point at it. Descriptors as set out in the AMA CPT code set.

The table below sets out each code’s descriptor, site, and the detail that separates it from 21030.

CodeDescriptorSiteKey differentiator
21029Removal by contouring of benign tumor of facial bone (e.g., fibrous dysplasia)Facial bonesA contouring procedure that reshapes the bone, not enucleation or curettage of a lesion
21030Excision of benign tumor or cyst of maxilla or zygoma by enucleation and curettageMaxilla, zygomaBenign bony lesion only, confirmed by pathology
21031Excision of torus mandibularisMandibleTorus mandibularis, a bony outgrowth on the inner mandible, not a tumor or cyst
21032Excision of maxillary torus palatinusMaxilla (palate)Torus palatinus, a bony growth on the hard palate, not a tumor or cyst
21034Excision of malignant tumor of maxilla or zygomaMaxilla, zygomaMalignant diagnosis required, with a wider surgical scope and different documentation
21040Excision of benign tumor or cyst of mandible by enucleation and/or curettageMandibleSame procedure as 21030 at the mandible, and the most common mix-up
41825Excision of lesion or tissue of dentoalveolar structuresDentoalveolar soft tissueSoft-tissue lesion, used when no bony involvement is documented

Pro Tip

When the operative note documents bony and soft-tissue lesion removal in one session, check whether both 21030 and 41825 apply. Then decide whether Modifier 51 belongs on the claim. Payers handle this pairing differently, so check the specific plan’s bundling rules before submitting.

Modifiers for CPT code 21030

The modifiers that apply to CPT code 21030 fall into two groups. Modifiers 22, 50 and 51 change how the claim is priced. LT/RT and Modifier 59 describe where and how the work was done without changing the base payment.

ModifierWhen to useDocumentation requiredPayer notes
Modifier 22Procedure substantially more complex than typical, such as a larger lesion, scarring, or anatomical variationOperative note must detail the factors that increased complexity. A cover letter explaining the added work is strongly recommendedAny increase is at the payer’s discretion. Expect a manual review of every Modifier 22 claim
Modifier 50 or LT / RTLesions excised on both sides on the same date of serviceOperative note must name both sidesThe CMS bilateral surgery indicator for 21030 is 1, so Medicare pays 150% on one line with Modifier 50. Some payers want two lines with LT and RT instead
Modifier 5121030 billed with a second surgical procedure on the same dateList the highest-valued procedure first and apply Modifier 51 to the secondary code21030 carries multiple procedure indicator 2, so the secondary procedure pays at 50%. Confirm bundling edits before billing
Modifier 59Distinct procedural service performed at a separate site or during a separate sessionDocumentation must clearly show separate sites or separate sessionsUse it to override a bundling edit only when the procedures are distinct. Overuse triggers audits

2026 Medicare reimbursement and fee schedule for CPT 21030

Medicare pays CPT code 21030 from the relative value units (RVUs) in the Medicare Physician Fee Schedule (MPFS). The total RVUs are multiplied by the conversion factor and adjusted by the Geographic Practice Cost Index (GPCI). For CY2026 the work RVU is 4.79, and the national rate is about $338 in a facility and $478 outside one. Your allowed amount will differ by Medicare Administrative Contractor (MAC) locality.

RVU component2026 valueNotes
Work RVU (wRVU)4.79Reflects surgeon time, skill, and clinical judgment
Practice expense RVU4.70 facility / 8.87 non-facilityCovers overhead, so the facility and non-facility rates differ
Malpractice RVU0.59Reflects the professional liability insurance component
Total RVUs10.08 facility / 14.25 non-facilityThe sum of the three components above
National payment, qualifying APM participants$338.36 facility / $478.34 non-facilityTotal RVUs x the $33.5675 conversion factor, before GPCI
National payment, other clinicians$336.68 facility / $475.96 non-facilityTotal RVUs x the $33.4009 conversion factor, before GPCI
Global period090 daysRoutine post-operative visits for 90 days are included in the payment

These values come from the CMS CY2026 relative value file (RVU26D, October 2026 release). For your locality’s rate, use the CMS Physician Fee Schedule lookup tool. The FastRVU 2026 RVU lookup applies GPCI by ZIP code if you want a quicker estimate.

Commercial payment for CPT code 21030 varies widely from the Medicare rate. It depends on the contract you hold with each payer.

Prior authorization requirements for CPT 21030

Medicare does not require prior authorization for CPT code 21030 in an office or outpatient surgical setting, as of this writing. Confirm against the CMS prior-authorization lists before you schedule. Commercial payers are a different story.

Many commercial and managed care plans require prior authorization for surgical excision codes in this range. That applies most often in an ambulatory surgical center or hospital outpatient setting. The specific requirement depends on the patient’s plan. No single answer covers every plan, so verify with the specific payer before scheduling.

When prior auth is required, the documentation package typically includes:

  • A clinical note documenting symptoms and examination findings
  • Pre-operative imaging, such as a CT or panoramic radiograph
  • The proposed diagnosis codes, such as D16.4, K09.0 or M27.49
  • The procedure code and the facility type

Some plans also require a letter of medical necessity from the treating surgeon. A medical billing compliance protocol for surgical codes gives the practice one prior auth workflow to follow.

When authorization is denied, the appeal generally needs more clinical evidence from the surgeon. Failed conservative treatment or documented growth of the lesion over time are typical examples. Local Coverage Determinations (LCDs) published by your MAC may add medical necessity criteria beyond the CPT descriptor. Check the applicable LCD before you submit the auth request.

Common claim denial reasons and how to avoid them

CPT code 21030 claims are denied for predictable reasons. Each one has a corresponding prevention action that can be built into the pre-submission workflow.

Denial reasonPrevention action
Wrong ICD-10 pairing (soft-tissue code for a bony lesion)Cross-check the operative note against the ICD-10 code. A bony lesion takes D16.4, K09.0 or M27.49, not a soft-tissue code
Missing pathology reportHold the 21030 claim until the pathology report confirms a benign diagnosis. Attach the report if the payer requires it
Prior authorization not obtainedCheck auth requirements when you schedule, not when you bill. Put the auth number on the claim
Code billed for mandibular lesion (should be 21040)Add a site check to the coding checklist. Confirm maxilla or zygoma in the operative note before assigning 21030
Unbundling error with 21029 or 41825Use the most specific code. Bill an adjacent code only when the note documents a distinct procedure
Medical necessity not establishedInclude clinical notes documenting symptoms, duration, and imaging findings supporting the need for surgical intervention

Structured denial management workflows catch these patterns before they repeat across claims. A denial log sorted by reason code shows which workflow step fails most often. The denial codes guide maps each CARC to its usual fix.

Pro Tip

Run a quarterly audit of all 21030 claims by denial reason code. If wrong ICD-10 pairings make up a large share of denials, the fix belongs at the coder-to-chart handoff. Add a site check to chart review before coding starts.

How Pabau supports CPT 21030 claims and prior authorization

Surgical excision codes like CPT code 21030 have more moving parts than a standard E/M claim. Pathology confirmation, site verification, modifier selection, and prior auth tracking all happen before submission. A missed step at any point can produce a denial that takes weeks to appeal.

Pabau’s claims management software submits 21030 claims electronically through Claim.MD as CMS-1500/837P claims. It runs eligibility checks before the visit and handles secondary claims. ERA remittances return to the patient record, so each denial code sits next to the claim that triggered it.

Pabau checkout screen with a completed invoice
Pabau’s checkout records the insurer’s share and the patient’s share on one invoice, so the balance on a 21030 case never sits unassigned.

Prior authorization gets the same treatment. Pabau tracks the authorization code, dates and sessions on the case and warns when one is missing. That flags a missing auth before the claim goes out, not after the denial comes back. Pair it with sound medical billing fundamentals and a clean claim checklist covering pathology, site and modifiers.

Reduce CPT 21030 claim denials with smarter billing workflows

Pabau submits CPT 21030 claims through Claim.MD, runs eligibility checks, and brings ERA denial codes into the patient record. It also tracks prior authorization codes and warns when one is missing.

Pabau claims management dashboard

Conclusion

CPT code 21030 pays cleanly when four facts line up in the record. The lesion is benign, the site is the maxilla or zygoma, the pathology report is attached, and the ICD-10 code matches it. Put the site and pathology checks into chart review, before coding starts, and most of the rework on this code stops.

Pabau’s integrated clearinghouse billing tracks prior auth status and brings ERA denial codes into one place. The patterns behind repeat 21030 denials then show up early enough to fix. Book a demo to see how it handles surgical excision claims in your practice.

Continue your research

Continue your research

Need to understand how clearinghouse billing works for surgical codes? Medical claims clearinghouse guide explains how clearinghouses validate, route, and report on claims before they reach the payer.

Getting denials with CARC codes you don’t recognise? Denial codes in medical billing breaks down the most common CARC and RARC codes and what each one means for your appeal.

Want to see the full 837P claim lifecycle for surgical procedures? 837 file guide covers how the electronic claim file is structured and what payers validate at each stage.

Frequently asked questions about CPT code 21030

What does CPT code 21030 cover?

CPT code 21030 covers excision of a benign tumor or cyst of the maxilla or zygoma by enucleation and curettage. It applies only to bony lesions at those two anatomical sites confirmed as benign by pathology. Soft-tissue lesions of the same region are billed under different codes, and mandibular lesions use CPT 21040.

How does CPT 21030 differ from CPT 21032 and CPT 21034?

CPT 21032 covers excision of a torus palatinus, a bony outgrowth on the hard palate, not a tumor or cyst. CPT 21034 covers excision of a malignant tumor of the maxilla or zygoma, with a wider surgical scope and malignancy confirmed by pathology. Use 21030 when the lesion is benign and located on the maxilla or zygomatic bone.

What is the work RVU for CPT code 21030?

The work RVU for CPT 21030 is 4.79 in the CY2026 Medicare Physician Fee Schedule. Total RVUs are 10.08 in a facility and 14.25 outside one. CMS updates the values each January, so check the current relative value file before you quote a figure.

When does Modifier 22 apply to CPT 21030?

Modifier 22 applies when the procedure takes substantially more time and effort than a typical 21030 case. A large or multi-lobed lesion, scarring from prior surgery, or difficult access can qualify. The operative note must document the factors that increased difficulty. A cover letter explaining the added work is recommended. Reimbursement adjustment is payer-discretionary and not guaranteed.

Avatar photo
Despina Petrushevska
Content Writer

Despina Petrushevska is a content writer covering aesthetics, dermatology, and clinic operations, known for making detailed clinical concepts clear and engaging. Outside of work, she enjoys photography, weekend getaways, and finding inspiration in everyday experiences.
×